FDA Inspection 1021285 — Guangdong CR Shunfeng Pharmaceutical Co., Ltd.
The FDA completed an inspection of Guangdong CR Shunfeng Pharmaceutical Co., Ltd. on July 14, 2017 in Foshan City. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- July 14, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Foshan City (China)